Lung Diagnostics Ltd

1. GlaxoSmithKline, LLC. $1,347,426 434 payments
2. Pfizer Inc. $236,410 44 payments
3. Boehringer Ingelheim Pharmaceuticals, Inc. $36,765 2 payments
4. Noven Pharmaceuticals, Inc. $22,730 3 payments
5. Sanofi US Services Inc. $8,400 1 payment
6. BioNTech SE $3,100 2 payments
7. Mylan Specialty L.P. $1,500 1 payment
8. Eli Lilly and Company $11 1 payment

1. Study name not reported $828,767 195 payments
2. A Phase 3 Placebocontrolled Randomized Observerblinded Study to Evaluate the Efficacy Safety and Tolerability of A Clostridium Difficile Vaccine in Adults 50 Years of Age and Older $213,465 36 payments
3. A Phase 3, Randomized, Placebo-Controlled, Observer-Blind, Multi-Count $137,650 33 payments
4. RSV Oa=Adj-002 $125,340 43 payments
5. Zoster-049 $61,874 71 payments
6. A Randomized, Adaptive, Double-Blind, Placebo-Controlled, Parallel-Arm $45,930 9 payments
7. Immunogenicity, Safety, Reactogenicity and Persistence of An Investiga $31,878 17 payments
8. A Phase III, Randomized, Controlled, Observer-Blind Study to Demonstra $31,847 23 payments
9. A Phase I/II, Randomized, Placebo-Controlled, Observer-Blind, Multicen $26,974 16 payments
10. A Phase 3 Randomized Doubleblind Trial to Evaluate the Safety and Immunogenicity of A 20Valent Pneumococcal Conjugate Vaccine 20Vpnc When Coadministered With Seasonal Inactivated Influenza Vaccine Siiv in Adults 65 Years of Age $22,945 8 payments

1. Patient care $100 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.